Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
- PMID: 15750215
- DOI: 10.3233/jad-2005-7107
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Abstract
The neurodegeneration that occurs in sporadic Alzheimer's disease (AD) is consistently associated with a number of characteristic histopathological, molecular, and biochemical abnormalities, including cell loss, abundant neurofibrillary tangles and dystrophic neurites, amyloid-beta deposits, increased activation of pro-death genes and signaling pathways, impaired energy metabolism/mitochondrial function, and evidence of chronic oxidative stress. The general inability to convincingly link these phenomena has resulted in the emergence and propagation of various heavily debated theories that focus on the role of one particular element in the pathogenesis of all other abnormalities. However, the accumulating evidence that reduced glucose utilization and deficient energy metabolism occur early in the course of disease, suggests a role for impaired insulin signaling in the pathogenesis of AD. The present work demonstrates extensive abnormalities in insulin and insulin-like growth factor type I and II (IGF-I and IGF-II) signaling mechanisms in brains with AD, and shows that while each of the corresponding growth factors is normally made in central nervous system (CNS) neurons, the expression levels are markedly reduced in AD. These abnormalities were associated with reduced levels of insulin receptor substrate (IRS) mRNA, tau mRNA, IRS-associated phosphotidylinositol 3-kinase, and phospho-Akt (activated), and increased glycogen synthase kinase-3beta activity and amyloid precursor protein mRNA expression. The strikingly reduced CNS expression of genes encoding insulin, IGF-I, and IGF-II, as well as the insulin and IGF-I receptors, suggests that AD may represent a neuro-endocrine disorder that resembles, yet is distinct from diabetes mellitus. Therefore, we propose the term, "Type 3 Diabetes" to reflect this newly identified pathogenic mechanism of neurodegeneration.
Similar articles
-
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.J Alzheimers Dis. 2005 Dec;8(3):247-68. doi: 10.3233/jad-2005-8304. J Alzheimers Dis. 2005. PMID: 16340083
-
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.J Alzheimers Dis. 2006 Mar;9(1):13-33. doi: 10.3233/jad-2006-9102. J Alzheimers Dis. 2006. PMID: 16627931
-
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.J Alzheimers Dis. 2005 Feb;7(1):45-61. doi: 10.3233/jad-2005-7106. J Alzheimers Dis. 2005. PMID: 15750214 Review.
-
Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.J Alzheimers Dis. 2017;55(2):849-864. doi: 10.3233/JAD-160656. J Alzheimers Dis. 2017. PMID: 27802237 Free PMC article.
-
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Prog Neurobiol. 2013. PMID: 23850509 Review.
Cited by
-
Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease.Alzheimers Dement (Amst). 2024 May 25;16(2):e12603. doi: 10.1002/dad2.12603. eCollection 2024 Apr-Jun. Alzheimers Dement (Amst). 2024. PMID: 38800123 Free PMC article.
-
Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study.Alzheimers Dement (Amst). 2024 May 20;16(2):e12593. doi: 10.1002/dad2.12593. eCollection 2024 Apr-Jun. Alzheimers Dement (Amst). 2024. PMID: 38770381 Free PMC article.
-
Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions.Int J Mol Sci. 2024 Apr 24;25(9):4651. doi: 10.3390/ijms25094651. Int J Mol Sci. 2024. PMID: 38731870 Free PMC article.
-
Role of the Insulin-like Growth Factor System in Neurodegenerative Disease.Int J Mol Sci. 2024 Apr 20;25(8):4512. doi: 10.3390/ijms25084512. Int J Mol Sci. 2024. PMID: 38674097 Free PMC article. Review.
-
Lycium Barbarum Polysaccharides Improves Cognitive Functions in ICV-STZ-Induced Alzheimer's Disease Mice Model by Improving the Synaptic Structural Plasticity and Regulating IRS1/PI3K/AKT Signaling Pathway.Neuromolecular Med. 2024 Apr 23;26(1):15. doi: 10.1007/s12017-024-08784-3. Neuromolecular Med. 2024. PMID: 38653878
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical